INO vs ZION · $88.0M cap vs P/E 11, rev $354.0M
Inovio Pharmaceuticals Inc (INO) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
INO currently screens at market cap $88.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the INO and ZION stock pages for the full models.
Not investment advice.